存檔於此部分的持續進修課題不設 CME / CNE / PEM 學分。

• The Success of Methadone Treatment Programme in Protecting Hong Kong from an HIV Epidemic among Drug Users
  (adopted from Public Health & Epidemiology Bulletin. Apr 2010, pp 10-14.)
  (21 October 2010)

• Epidemiology of hepatitis B and hepatitis C in Hong Kong
  (Adopted from Surveillance of Viral Hepatitis in Hong Kong - Update report 2008)
  (22 July 2010)

• Review of 2008 HIV situation in Hong Kong
  (Adopted from HIV surveillance report – 2008 Update, SPP, CHP, DH December 2009)
  (12 April 2010)

• The Use of BCG Vaccine in HIV Infected Patients
  (Adopted from SCAS, CHP, DH November 2009)
  (26 January 2010)

• Quality assurance guidelines on HIV voluntary counselling and testing services in community settings
  (Adopted from Community Forum on AIDS of the Hong Kong Advisory Council on AIDS, October 2009)
  (16 October 2009)

• Dermatologic manifestations in HIV disease
  (Adopted from HIV Manual 2007)
  (July 2009)

• Review of 2007 HIV situation in Hong Kong
  (Adopted from HIV surveillance report - 2007 Update, SPP, CHP, DH December 2008)
  (April 2009)

• Recommendations on the Management of HIV/Hepatitis B virus co-infection (Adopted from SCAS, CHP, DH October 2008)
  (January 2009)

• Recommendations on the Management of Human Immunodeficiency Virus and Tuberculosis Coinfection (Adopted from Scientific Committee on AIDS and STI (SCAS), Centre for Health Protection, Department of Health, July 2008)
  (October 2008)

• HIV/AIDS Epidemiology in Hong Kong - 2006 (Adopted from HIV Surveillance Report -2006 Update.)
  (July 2008)

• Antiretroviral Therapy (Adopted from HIV Manual 2007)
  (April 2008)

• Recommendations on the Management and Postexposure Prophylaxis of Needlestick Injury or Mucosal Contact to HBV, HCV and HIV. (Adopted from Scientific Committee on AIDS and STI. Sep 2007.)
  (January 2008)

• HIV testing programmes. Adopted from HIV Manual 2007.
  (October 2007)

• Staging, classification and monitoring of HIV/AIDS. Adopted from HIV Manual 2007.
  (July 2007)

• Extract of final draft on "Recommended HIV/AIDS Strategies for Hong Kong 2002-2011"
  (April 2007)

• "Recommended clinical guidelines on the prevention of perinatal HIV transmission" - Scientific Committee on AIDS and STI, Centre for Health Protection, Department of Health.
  (January 2007)

• Community Assessment and Evaluation of HIV Prevention among Injecting Drug Users- Extract of Report of Working Group on HIV Prevention among Injecting Drug Users in Hong Kong
  (October 2006)

• Using antiretrovirals for post exposure prophylaxis against HIV in the non-occupational setting - Position Statement of the SCAS
  (July 2006)

• Epidemiology and enhanced surveillance of hepatitis C in Hong Kong
  (April 2006)

• Surveillance and epidemiology of HIV/AIDS in Hong Kong 2004
  (January 2006)

• Unlinked anonymous screening for HIV surveillance in Hong Kong 1997-2004
  (October 2005)

• Recommended Framework for the Delivery of HIV Clinical Care in Hong Kong
  (July 2005)

• Recommendations on Infection Control Practice for HIV Transmission in Health Care Settings
  (April 2005)

• Recommended Ethical Principles on Partner Counselling and Referral for HIV Infected Individuals in Hong Kong
  (Jan 2005)

• A Draft Recommended Principles of Antiretroviral Therapy in HIV Disease (Scientific Committee on AIDS, March 2004)
  (October 2004)

• Recommended Ethical Principles Regarding the Use of Assisted Reproduction in HIV Infected Individuals
  (July 2004)

• Epidemiology of hepatitis B infection in Hong Kong
  (April 2004)

• Summary Review Of HIV/AIDS In Hong Kong 2002
  (December 2003)

• Recommendations on the Management and Postexposure Prophylaxis of Needlestick Injury or Mucosal Contact to HBV, HCV and HIV
  (May 2003)

• The Pattern of AIDS Reporting and the Implications on HIV Surveillance
  (Dec 2002)

• 預防圍產期愛滋病傳播的建議臨床指引
  (Aug 2002)

• Recommended Clinical Guidelines on the Prevention of Perinatal HIV Transmission
  (Dec 2001)